Cholecystokinin peptides and receptors in the rat brain during stress

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 1, 1996, Pages 59-66

  Harro, Jaanus ^a,b   Löfberg, Charlotta ^a   Rehfeld, Jens F ^c   Oreland, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF TARTU   (Estonia)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adaptation; Anxiety; CCK(B) receptors; Cholecystokinin; Diazepam; Stress

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CERULETIDE; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ DERIVATIVE; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ PENTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; DEVAZEPIDE; DIAZEPAM; PD 135158; RADIOLIGAND; RECEPTOR SUBTYPE; TETRAGASTRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; LIGAND BINDING; MALE; NONHUMAN; RADIOIMMUNOASSAY; RAT; RECEPTOR BINDING; SEPTUM NUCLEUS; STRESS;

EID: 0029974949     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00168707     Document Type: Article

References (28)

1. Abelson JL, Nesse RM, Vinik A (1991) Stimulation of corticotropin release by pentagastrin in normal subjects and patients with panic disorder. Biol Psychiatry 29:1220-1223
2. Bacarese-Hamilton AJ, Adrian TE, Bloom SR (1985) Prevention of cholecystokinin oxidation during tissue extraction. In: Vanderhaeghen J-J, Crawley JN (eds) Ann N Y Acad Sci: Neuronal cholecystokinin, vol 448. New York Academy of Sciences. New York, pp 571-572
3. Biggio G (1983) The action of stress, β-carbolines, diazepam and Ro 15-1788 on GABA receptors in the rat brain. In: Biggio G, Costa E (eds) Benzodiazepine recognition site ligands: biochemistry and pharmacology. Raven Press. New York, pp 105-119
4. Bradwejn J, Koszycki D, Couetoux du Tertre A, Bourin M, Palmour R, Ervin F (1992) The cholecystokinin hypothesis of panic and anxiety disorders: a review. J Psychopharmacol 6:345-351
5. Brodin E, Rosen A, Schott E, Brodin K (1994) Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periagueductal grey and limbic regions. Neuropeptides 26:253-260
6. Brodin K, Ögren S-O, Brodin E (1994) Clomipramine and clonazepam increase cholecystokinin levels in rat ventral tegmental area and limbic regions. Eur J Pharmacol 263:175-180
7. Cantor P, Rehfeld JF (1985) Radioimmunoassay of cholecystokinin: comparison of different tracers. J Immunol Methods 82:47-55
8. Harro J, Kiivet R-A, Lang A, Vasar E (1990a) Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics. Behav Brain Res 39:63-71
9. Harro J, Lang A, Vasar E (1990b) Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain. Eur J Pharmacol 180:77-83
10. Harro J, Marcusson J, Oreland L (1992) Alterations in brain cholecystokinin receptors in suicide victims. Eur Neuropsychopharmacol 2:57-63
11. Harro J, Vasar E, Bradwejn J (1993) CCK in animal and human research on anxiety. Trends Pharmacol Sci 14:244-249
12. Harro J, Wahlström G, Oreland L (1994) Cholecystokinin receptor binding after long-term ethanol treatment in rats. Alcohol Alcohol 29:575-581
13. Harro J, Vasar E, Koszycki D, Bradwejn J (1995) Cholecystokinin in panic and anxiety disorders. In: Panksepp J (ed) Advances in biological psychiatry, vol 1. JAI Press, pp 235-262
14. B receptors in the rat brain. Mol Cell Neurosci 4:143-154
15. B/gastrin receptor in guinea pig cerebral cortex and gastric mucosa. Mol Pharmacol 43:595-602
16. Leatherbarrow RJ (1987) Enzfitter, a non-linear regression data analysis program for the IBM PC. Elsevier, Amsterdam
17. Löfberg C, Harro J, Gottfries C-G, Oreland L (1996) Cholecystokinin peptides and receptor binding in Alzheimer's disease. J Neural Transm (in press)
18. Pavlasevic S, Bednar I, Qureshi GA, Södersten P (1993) Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety. Neuroreport 5:225-228
19. Pratt JA, Brett RR (1995) The benzodiazepine receptor inverse agonist FG 7142 induces cholecystokinin gene expression in rat brain. Neurosci Lett 184:197-200
20. Rattray M, Singhvi S, Wu P-Y, Andrews N, File SE (1993) Benzodiazepines increase preprocholecystokinin messenger RNA levels in rat brain. Eur J Pharmacol [Mol Pharmacol Sect] 245:193-196
21. Rehfeld JK, Hansen HK (1986) Characterization of preprocholecystokinin products in the porcine cerebral cortex. J Biol Chem 261:5832-5840
22. Rosen A, Brodin K, Eneroth P, Brodin E (1992) Short-term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri-aqueductal grey and limbic regions of rat brain. Acta Physiol Scand 146:341-348
23. Siegel RA, Düker E-M, Fuchs E, Pahnke U, Wuttke W (1984) Responsiveness of mesolimbic, mesocortical, septal and hippocampal cholecystokinin and substance P systems to stress, in male rat. Neurochem Int 6: 783-789
24. Takamatsu Y, Yamamoto H, Ogunremi OO, Matsuzaki I, Moroji T (1991) The effects of corticotropin-releasing hormone on peptidergic neurons in the rat forebrain. Neuropeptides 20:255-265
25. Van Megen HJGM, Westenberg HGM, Den Boer JA, Haigh JRM, Traub M (1994) Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients. Psychopharmacology 114:449-455
26. Vasar E, Peuranen H, Harro J, Lang A, Oreland L, Männistö PT (1993) Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein. Naunyn-Schmiedeberg's Arch Pharmacol 348:96-101
27. Welin M, Harro J, Yukhananov R, Nyberg F, Oreland L (1994) Cholecystokinin receptor binding in morphine analgesia, tolerance, withdrawal and abstinence. Neuropeptides 26:379-383
28. Wiertelak EP, Maier SF, Watkins LR (1992) Cholecystokinin anti-analgesia: safety cues abolish morphine analgesia. Science 256:830-833